A detailed history of Caxton Associates LP transactions in Pfizer Inc stock. As of the latest transaction made, Caxton Associates LP holds 76,625 shares of PFE stock, worth $2.05 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
76,625
Previous 26,393 190.32%
Holding current value
$2.05 Million
Previous $738,000 200.41%
% of portfolio
0.08%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $1.39 Million - $1.58 Million
50,232 Added 190.32%
76,625 $2.22 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $666,687 - $781,232
26,393 New
26,393 $738,000
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $97,649 - $114,142
3,043 Added 7.25%
45,018 $1.49 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $1.52 Million - $1.75 Million
41,975 New
41,975 $1.54 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $367,149 - $479,273
8,794 Added 0.31%
2,874,544 $147 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $944,340 - $1.15 Million
-21,580 Reduced 0.75%
2,865,750 $125 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $89,895 - $106,588
-1,932 Reduced 0.07%
2,887,330 $151 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $22.8 Million - $28.3 Million
498,845 Added 20.87%
2,889,262 $150 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $37.6 Million - $55.8 Million
910,417 Added 61.51%
2,390,417 $141 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $58.1 Million - $74.6 Million
1,480,000 New
1,480,000 $63.7 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $433,688 - $492,180
-13,174 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $428,023 - $555,020
13,174 New
13,174 $473,000
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $348,422 - $422,615
-10,108 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $333,361 - $355,397
10,108 New
10,108 $367,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.